Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
TFX Quote, Financials, Valuation and Earnings
Last price:
$113.66
Seasonality move
:
1.38%
Day range:
$112.32 - $114.63
52-week range:
$112.32 - $249.91
Dividend yield:
1.2%
P/E ratio:
35.75x
P/S ratio:
1.76x
P/B ratio:
1.22x
Volume:
684K
Avg. volume:
531K
1-year change:
-50.58%
Market cap:
$5B
Revenue:
$3B
EPS (TTM):
$3.17
Analysts' Opinion
-
Consensus RatingTeleflex has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 11 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $151.02, Teleflex has an estimated upside of 33.27% from its current price of $113.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $130.00 representing -14.72% downside risk from its current price of $113.32.
Fair Value
-
According to the consensus of 12 analysts, Teleflex has 33.27% upside to fair value with a price target of $151.02 per share.
TFX vs. S&P 500
-
Over the past 5 trading days, Teleflex has underperformed the S&P 500 by -4.78% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Teleflex does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Teleflex revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Teleflex reported revenues of $700.7M.
Earnings Growth
-
Teleflex has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Teleflex reported earnings per share of $2.07.
Enterprise value:
6.6B
EV / Invested capital:
--
Price / LTM sales:
1.76x
EV / EBIT:
22.89x
EV / Revenue:
2.20x
PEG ratio (5yr expected):
--
EV / Free cash flow:
13.82x
Price / Operating cash flow:
11.04x
Enterprise value / EBITDA:
11.72x
Gross Profit (TTM):
$1.7B
Return On Assets:
2.04%
Net Income Margin (TTM):
4.96%
Return On Equity:
3.41%
Return On Invested Capital:
2.43%
Operating Margin:
18.6%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.9B | $3B | $3B | $737.8M | $700.7M | |
| Gross Profit | $1.6B | $1.7B | $1.7B | $416.1M | $389.4M | |
| Operating Income | $524.8M | $581.5M | $540.1M | $136M | $130.3M | |
| EBITDA | $744.7M | $648.5M | $565.5M | $62.9M | $194.8M | |
| Diluted EPS | $7.67 | $6.23 | $3.17 | $0.32 | $2.07 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.5B | $1.4B | $1.4B | $1.5B | |
| Total Assets | $7B | $6.9B | $6.9B | $7.5B | $7.2B | |
| Current Liabilities | $508.1M | $656.2M | $575.7M | $571M | $675.9M | |
| Total Liabilities | $3.7B | $3.1B | $2.8B | $3B | $3.1B | |
| Total Equity | $3.4B | $3.8B | $4.1B | $4.5B | $4.1B | |
| Total Debt | $2.4B | $1.9B | $1.6B | $1.8B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $364.2M | $537.6M | $597.9M | $111M | $73.1M | |
| Cash From Investing | -$267M | -$624.1M | -$103.3M | -$24.8M | -$28.8M | |
| Cash From Financing | -$290.1M | $60.7M | -$410M | -$71.4M | -$59.5M | |
| Free Cash Flow | $276.3M | $429.5M | $479.8M | $72.5M | $43.1M | |
TFX
Sector
Market Cap
$5B
$34.4M
Price % of 52-Week High
45.35%
48.88%
Dividend Yield
1.2%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
-50.58%
-37.36%
Beta (5-Year)
1.080
0.614
Dividend yield:
1.2%
Annualized payout:
$1.36
Payout ratio:
41.99%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$116.77
200-day SMA
Sell
Level
$164.52
Bollinger Bands (100)
Sell
Level
117.26 - 143.4
Chaikin Money Flow
Sell
Level
-801.3K
20-day SMA
Sell
Level
$118.29
Relative Strength Index (RSI14)
Sell
Level
35.47
ADX Line
Sell
Level
21.12
Williams %R
Buy
Level
-91.4126
50-day SMA
Sell
Level
$121.41
MACD (12, 26)
Buy
Level
31.47
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-1.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2064)
Buy
CA Score
(Annual)
Level (0.2366)
Buy
Beneish M-Score
(Annual)
Level (-2.8571)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.0077)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Stock Forecast FAQ
In the current month, TFX has received 1 Buy ratings 11 Hold ratings, and 0 Sell ratings. The TFX average analyst price target in the past 3 months is $151.02.
-
Where Will Teleflex Stock Be In 1 Year?
According to analysts, the consensus estimate is that Teleflex share price will rise to $151.02 per share over the next 12 months.
-
What Do Analysts Say About Teleflex?
Analysts are divided on their view about Teleflex share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Teleflex is a Sell and believe this share price will drop from its current level to $130.00.
-
What Is Teleflex's Price Target?
The price target for Teleflex over the next 1-year time period is forecast to be $151.02 according to 12 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is TFX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Teleflex is a Hold. 11 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TFX?
You can purchase shares of Teleflex via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Teleflex shares.
-
What Is The Teleflex Share Price Today?
Teleflex was last trading at $113.66 per share. This represents the most recent stock quote for Teleflex. Yesterday, Teleflex closed at $113.32 per share.
-
How To Buy Teleflex Stock Online?
In order to purchase Teleflex stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
